• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外衬里内皮:初始完整性和超微结构事件。

In vitro-lined endothelium: initial integrity and ultrastructural events.

作者信息

Zilla P, Preiss P, Groscurth P, Rösemeier F, Deutsch M, Odell J, Heidinger C, Fasol R, von Oppell U

机构信息

Department of Cardio-Thoracic Surgery, University of Cape Town Medical School, South Africa.

出版信息

Surgery. 1994 Sep;116(3):524-34.

PMID:8079183
Abstract

BACKGROUND

The early fate of in vitro-endothelialized prosthetic vascular grafts was assessed in the nonhuman primate.

METHODS

Each of 17 male chacma baboons received a control and a confluently endothelialized 4 mm polytetrafluoroethylene graft in femoro-femoral positions (8.2 +/- 0.8 cm). All experimental grafts were precoated with fibrinolytically inhibited fibrin glue and lined with cultured autologous endothelial cells (EC) from the external jugular vein. The average time period needed to obtain first-passage mass-cultures sufficient for preconfluent graft endothelialization was 19.8 +/- 5.2 days. Before implantation in vitro-lined grafts were kept in culture for another 16.1 +/- 4.3 days to achieve complete confluence and maturation of the EC cytoskeleton.

RESULTS

After 9 days of implantation, endothelial-lined grafts still showed a confluent endothelium that was free of any fibrin deposits. However, the EC density was significantly lower than at implantation (39.7 +/- 7.6 x 10(3) versus 59.9 +/- 8.5 x 10(3) EC/cm2; p < 0.05), and occasional 10-microns-wide intercellular gaps with adherent platelets and leukocytes were visible. Transmission electron microscopy showed leukocytes and cell debris in the underlying fibrin glue. After 4 weeks of implantation, the endothelium of experimental prostheses had regained a high cell density (72.7 +/- 10.5 x 10(3) EC/cm2) with a mature and well-differentiated morphologic appearance. At both observation periods, the surface of control grafts showed a wide range from fibrin deposits to an amorphous protein coverage containing spread platelets.

CONCLUSIONS

The endothelium of in vitro-endothelialized vascular prostheses remains confluent after implantation and is nonthrombogenic in spite of a moderate initial cell loss.

摘要

背景

在非人灵长类动物中评估了体外内皮化人工血管移植物的早期转归。

方法

17只雄性 chacma 狒狒,每只在股-股位置(8.2±0.8 cm)植入一个对照移植物和一个内皮细胞融合的4毫米聚四氟乙烯移植物。所有实验性移植物均预先用纤维蛋白溶解抑制的纤维蛋白胶包被,并内衬来自颈外静脉的培养自体内皮细胞(EC)。获得足以进行预融合移植物内皮化的首次传代大量培养所需的平均时间为19.8±5.2天。在植入前,体外内衬移植物在培养中再保存16.1±4.3天,以使EC细胞骨架完全融合和成熟。

结果

植入9天后,内皮内衬移植物仍显示内皮细胞融合,无任何纤维蛋白沉积。然而,EC密度明显低于植入时(39.7±7.6×10³ 对59.9±8.5×10³ EC/cm²;p<0.05),可见偶尔有10微米宽的细胞间隙,伴有黏附的血小板和白细胞。透射电子显微镜显示在下面的纤维蛋白胶中有白细胞和细胞碎片。植入4周后,实验性假体的内皮细胞密度恢复到较高水平(72.7±10.5×10³ EC/cm²),形态成熟且分化良好。在两个观察期,对照移植物的表面从纤维蛋白沉积到含有铺展血小板的无定形蛋白质覆盖物范围广泛。

结论

体外内皮化血管假体的内皮在植入后仍保持融合,尽管最初有适度的细胞丢失,但仍不形成血栓。

相似文献

1
In vitro-lined endothelium: initial integrity and ultrastructural events.体外衬里内皮:初始完整性和超微结构事件。
Surgery. 1994 Sep;116(3):524-34.
2
Implantation of in vitro endothelialized polytetrafluoroethylene grafts in human beings. A preliminary report.人体外膜内皮化聚四氟乙烯移植物的植入:初步报告。
J Thorac Cardiovasc Surg. 1992 Sep;104(3):736-42.
3
Use of fibrin glue as a substrate for in vitro endothelialization of PTFE vascular grafts.使用纤维蛋白胶作为聚四氟乙烯血管移植物体外内皮化的基质。
Surgery. 1989 Apr;105(4):515-22.
4
In vitro endothelialization of expanded polytetrafluoroethylene grafts: a clinical case report after 41 months of implantation.膨体聚四氟乙烯移植物的体外内皮化:植入41个月后的临床病例报告
J Vasc Surg. 1997 Apr;25(4):757-63. doi: 10.1016/s0741-5214(97)70307-0.
5
Clinical in vitro endothelialization of femoropopliteal bypass grafts: an actuarial follow-up over three years.
J Vasc Surg. 1994 Mar;19(3):540-8. doi: 10.1016/s0741-5214(94)70083-4.
6
Eight years of clinical endothelial cell transplantation. Closing the gap between prosthetic grafts and vein grafts.八年临床内皮细胞移植。弥合人工血管与静脉血管之间的差距。
ASAIO J. 1997 Sep-Oct;43(5):M515-21.
7
Extracellular matrix preparation of expanded polytetrafluoroethylene grafts seeded with endothelial cells: influence on early platelet deposition, cellular growth, and luminal prostacyclin release.接种内皮细胞的膨体聚四氟乙烯移植物的细胞外基质制备:对早期血小板沉积、细胞生长和管腔前列环素释放的影响。
Surgery. 1991 Mar;109(3 Pt 1):313-9.
8
Naturally produced extracellular matrix is an excellent substrate for canine endothelial cell proliferation and resistance to shear stress on PTFE vascular grafts.天然产生的细胞外基质是犬内皮细胞增殖以及聚四氟乙烯血管移植物抗剪切应力的优良底物。
Thromb Haemost. 1997 Nov;78(5):1392-8.
9
Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience.100例患者腹股沟下ePTFE移植物的临床自体体外内皮化:9年经验
Surgery. 1999 Nov;126(5):847-55.
10
In vitro lining of fibronectin coated PTFE grafts with cryopreserved saphenous vein endothelial cells.用冷冻保存的大隐静脉内皮细胞在体外对纤连蛋白包被的聚四氟乙烯移植物进行内衬。
Thorac Cardiovasc Surg. 1987 Nov;35 Spec No 2:143-7. doi: 10.1055/s-2007-1020277.

引用本文的文献

1
Cellularized small-caliber tissue-engineered vascular grafts: looking for the ultimate gold standard.细胞化小口径组织工程血管移植物:探寻终极金标准。
NPJ Regen Med. 2021 Aug 12;6(1):46. doi: 10.1038/s41536-021-00155-x.
2
Progressive Reinvention or Destination Lost? Half a Century of Cardiovascular Tissue Engineering.渐进式重塑还是迷失方向?心血管组织工程的半个世纪
Front Cardiovasc Med. 2020 Sep 9;7:159. doi: 10.3389/fcvm.2020.00159. eCollection 2020.
3
Physiologically Modeled Pulse Dynamics to Improve Function in In Vitro-Endothelialized Small-Diameter Vascular Grafts.
通过生理建模的脉搏动力学改善体外内皮化小口径血管移植物的功能。
Tissue Eng Part C Methods. 2015 Nov;21(11):1125-34. doi: 10.1089/ten.TEC.2015.0110. Epub 2015 Jun 24.
4
Protective constriction of coronary vein grafts with knitted nitinol.编织型镍钛诺保护冠状动脉静脉移植物的收缩。
Eur J Cardiothorac Surg. 2013 Jul;44(1):64-71. doi: 10.1093/ejcts/ezs670. Epub 2013 Jan 7.
5
Human endothelial progenitor cells.人内皮祖细胞。
Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006692. doi: 10.1101/cshperspect.a006692.